A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Cancer of the Breast|Breast Cancer
Interventions: DRUG: Gemcitabine|DRUG: Trastuzumab
Sponsor: Eli Lilly and Company